09.12.2009 • News

J & J to Acquire Cougar Biotechnology

Johnson & Johnson announced definitive agreement to acquire Cougar Biotechnology. The company will initiate a tender offer to buy all outstanding shares of Cougar Biotechnology at $43 per share. The Boards of both Johnson & Johnson and Cougar Biotechnology have ­approved the transaction. The deal is expected to close in the third quarter of 2009.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.